A detailed history of Driehaus Capital Management LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 871,944 shares of RNA stock, worth $25.2 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
871,944
Holding current value
$25.2 Million
% of portfolio
0.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$37.21 - $48.14 $32.4 Million - $42 Million
871,944 New
871,944 $40 Million
Q1 2023

May 15, 2023

SELL
$15.35 - $25.65 $578,741 - $967,081
-37,703 Reduced 10.73%
313,542 $4.81 Million
Q4 2022

Feb 14, 2023

BUY
$10.06 - $22.66 $3.53 Million - $7.96 Million
351,245 New
351,245 $7.79 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.51B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.